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Despite the useful information provided by myocardial con- 
trast echocardiography, the meaning of myocardial contrast in- 
tensity remains elusive. This review is meant to define the 
contribution of physical and biologic factors in producing myo- 
cardial contrast and to elucidate the relative roles of coronary 
blood flow and intramyocardial blood volume in determining 
contrast effect. The main physical factors influencing the contrast 
echo effect include the properties of microbubbles as scattering 
elements (mainly their radius, compressibility, stability and con- 
centration), electronic signal processing, instrument setting and 
contrast-induced signal attenuation. The effect of these factors 
can be limited by an appropriate experimental or clinical setup. 
Biologic factors are less easily controllable, and changes in 
coronary blood flow and alterations in myocardial blood volume 
appear to be the main determinants of myocardial contrast 
intensity. Moreover, these factors influence contrast intensity in 
opposite directions. Both the area under the time-intensity curve 
and the mean transit time of myocardial contrast are inversely 
related to coronary blood flow but directly related to myocardial 
vascularity and blood volume. Therefore, an increase in coronary 
flow not accompanied by an increase in myocardial vascularity 
and volume is accompanied by a decrease in the area under the 
curve and mean transit time of contrast. Conversely, an increase 
in coronary, flow mediated by augmented myocardial vascularity 
and volume will produce an increase in the area under the curve 
and mean transit time. A better understanding of the physical and 
biologic determinants of contrast echo intensity will be fundamen- 
tal in the clinical application of new agents and technologies. 
(J Am Coll Cardiol 1995;26:12-7) 
Opacification of the myocardium by intracoronary injection of 
an ultrasound contrast agent was first demonstrated in 1980 
(1). Subsequently, the injection of a variety of contrast agents 
into the left atrium, left ventricle, aorta or coronary circulation 
during echocardiography has been shown to increase the 
intensity of myocardial ultrasound signals, a phenomenon 
referred to as the myocardial contrast echo effect. The spatial 
distribution of this effect within the ventricular walls and the 
change in the intensity of myocardial contrast over time 
constitute the basis for the study of myocardial perfusion by 
contrast echocardiography. The myocardial contrast echo ef- 
fect appears to depend on a variety of factors, some of which 
are not yet completely understood. Thus, despite the useful 
information provided by myocardial contrast echocardiogra- 
phy (2-14) and the growing interest in this field, the meaning 
of regional myocardial contrast intensit 3,remains elusive and 
potential clinical applications of this technique remain uncer- 
tain. 
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Over the past few years several studies have been per- 
formed in our own and other laboratories with the aim of 
quanti~ing coronary blood flow by contrast echocardiography. 
These studies were performed in in vitro and experimental 
models of the coronary circulation, as well as in humans. 
Although shedding light on specific aspects of myocardial 
contrast, such studies have not provided a comprehensive 
understanding of this phenomenon. This review is meant o 
reevaluate hese studies in an attempt to define the contribu- 
tion of physical and biologic factors in producing myocardial 
contrast and to elucidate the relative role of coronary blood 
flow, intramyocardial blood volume or other factors in deter- 
mining contrast effect. 
Physical factors influencing the contrast echo effect. The 
major determinants of the intensity produced by a contrast 
agent are related to the properties of microbubbles as scatter- 
ing elements, mainly including the radius, compressibility and 
stability of microbubbles (15,16). For a given intensity of the 
incident ultrasound beam, the amplitude of the backscattered 
signal increases exponentially with the radius of microbubbles. 
Signal amplitude also increases with the compressibility of 
microbubbles. For this reason, one cannot produce ultrasound 
contrast by administering solid, incompressible microspheres. 
Furthermore, gas microbubbles are unstable and disappear 
quickly in the fluid; for instance, a10-/sin air bubble disappears 
within 6 s in water. This decrease in microbubble size is due to 
the diffusion of gas in the medium and is favored by surface 
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tension. Gas diffusion and microbubble collapse are responsi- 
ble for the inability to opacify the left side of the heart by 
intravenous injection of hand-agitated contrast agents. To 
overcome this limitation, pharmacologic companies have used 
several approaches, including a reduction in the surface ten- 
sion by a surfactant (17), microbubble protection by an albu- 
min coat (18) and the utilization of a gas with a very low 
solubility in blood (19). The dose of contrast agent is another 
obvious determinant of contrast echo intensity. In fact, con- 
trast intensity is influenced by the ratio between the dose 
injected and the distribution volume, which is contrast concen- 
tration. 
Contrast echo intensity also varies with the electronic signal 
processing. The relation between contrast concentration a d 
signal intensity (i.e., linear, logarithmic, sigma or other) largely 
depends on the type of processing (which varies with the 
different commercial scanners) and on the instrument setting 
selected by the operator (20,21). An increase in contrast echo 
intensity can also be obtained by increasing electronic signal 
amplification. However, signal amplification enhances both 
signal and noise levels, whereas an increment in contrast 
concentration ly enhances signal intensity. 
Furthermore, the intensity of contrast echo effect depends 
on the relation between microbubbles and ultrasound, which 
varies with contrast concentration. At low concentrations, the 
intensity of the backscattered signal increases with the concen- 
tration of the contrast agent; however, a plateau in signal 
intensity is reached at higher concentrations, and signal inten- 
sity may actually decrease at even higher concentrations 
(22,23). This phenomenon suggests that microbubbles behave 
like individual scatterers at low concentrations, whereas they 
form a kind of ultrasound shield, able to attenuate ultrasound 
energy, at higher concentrations. The investigators strive to 
prevent the plateau effect and contrast-induced attenuation by
injecting appropriate amounts of contrast agent in each exper- 
imental and clinical situation. Finally, the intensity of contrast 
echo effect is affected by signal attenuation due to both cardiac 
and extracardiac tissues intervening between the probe and the 
target (24). Thus, myocardial contrast intensity is also region- 
ally affected by differences in the amount of intervening 
myocardium (25,26). Although myocardial contrast is influ- 
enced by these physical factors, their effect can be limited by an 
appropriate xperimental or clinical setup. Specifically, the 
type and dose of contrast agent, signal processing, instrument 
setting, signal amplification and the geometric imaging condi- 
tions can all be kept constant during data collection. 
Biologic factors influencing myocardial contrast echo ef- 
fect. Biologic variables also play a significant role when assess- 
ing myocardial perfusion by contrast echocardiography. 
Among these variables, coronary blood flow, intramyocardial 
blood volume and coronary blood pressure have been postu- 
lated to be the main determinants of contrast echo effect. In 
the initial attempt to quantify myocardial perfusion by contrast 
echocardiography, Ten Care et al. (27) hypothesized that the 
myocardial contrast effect measured by intracoronary contrast 
injection would primarily reflect changes in coronary, blood 
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Figure I. In vitro study. Close inverse relation between the area under 
the contrast time-intensity curve and experimental pump flow. Re- 
drawn, with permission, from Figure 6 of Rovai et al. (30). 
flow. In fact, the washout rate of myocardial contrast produced 
by hand-agitated meglumine diatrizoate appeared to be related 
to the rate of coronary blood flow. Subsequently, Feinstein et 
al. (28) hypothesized that myocardial contrast was determined 
by myocardial blood content, or volume, in addition to coro- 
nary blood flow. Finally, the washout rate of myocardial echo 
contrast agents was also shown to be influenced by coronary 
perfusion pressure; however, the relative weight of this vari- 
able appeared to be significantly lower than that of coronary 
blood flow (29). 
Variable flow rate and constant distribution volume: in 
vitro data. To evaluate the effect of variable flow rate on 
contrast echo intensity, we conducted an in vitro study in which 
variables other than flow volume could be controlled (30). A 
constant dose of contrast agent (SHU 454, Schering AG, 
Germany) was injected as a bolus in an in vitro circulatory 
model. Injections were performed at different flow rates in the 
absence of recirculation while the volume and pressure of the 
system were kept constant. Two-dimensional echocardio- 
graphic images of a short-axis view of the circuit were obtained 
at constant gain settings. The images were digitized, aregion of 
interest was placed within the center of the circuit and mean 
video intensity was measured togenerate time-intensity curves. 
Several variables were extracted from each curve, including 
peak intensity, area under the curve and mean transit ime or 
washout half-time. 
In agreement with the Stewart-Hamilton principle (31), the 
area under the contrast ime-intensity curve was inversely 
related to actual flow rate (Fig. 1). In fact, flow calculated 
according to the equation F - K/AUC, where F is flow rate, K 
is a constant of the system (including a constant injected ose) 
and AUC is the area under the curve, provided a close 
correlation (correlation coefficient r = 0.93) with actual pump 
flow. Time-related variables were also in close agreement with 
tracer theory, and pump flow, calculated according to the 
equation F = K/t, where K is a constant of the system 
(including a constant distribution volume) and t is mean 
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transit ime, yielded a close correlation (r = 0.95) with actual 
flow. Thus, consistent with the mathematical model proposed 
by Feinstein et al. (28), if the dose of contrast agent, distribu- 
tion volume and gain setting controls are constant, and if 
contrast microbubbles do not interferc with the microcircula- 
tion, both the area under the curve and the mean contrast 
transit ime are inversely related to actual flow rate. 
Variable eorona~ blood flow: experimental data. To eval- 
uate the effects of variable coronary blood flow in vivo on 
myocardial contrast echo effect, a constant dose of contrast 
agent (sonicated iopamidol, Bracco S.p.A., Italy) was injected 
as a bolus into a cannulated coronary' artery in dogs (29). The 
coronary artery was perfused with blood drawn from the 
femoral artery and delivered by a roller pump. To minimize 
changes in intramyocardial blood volume, which may accom- 
pany changes in coronary tone, adenosine was continuously 
infused into the cannulated coronary artery to achicve maximal 
vasodilation. The efficacy of the adenosine infusion in abolish- 
ing coronary autorcgulation was documented by the lack of 
hyperemic response after brief periods of coronary occlusion. 
Thus, echo contrast injections were performed at variable 
coronary flow rates and, presumably, with minimal changes in 
coronary blood volume. Two-dimensional echocardiographic 
images of the left ventricu[ar short-axis view were obtained 
while gain setting controls were kept constant. Echocardio- 
graphic images were digitized and myocardial time-intensity 
curves were generated. For each curve, the area under thc 
curve and myocardial washout rate were measured. Attention 
was not paid to the time of myocardial contrast appearance 
because its short duration limits the reproducibility, and accu- 
racy of the measurements (32). 
Coronary transit imes of sonicated iopamidol appeared to 
be longer than expected from coronary physiology, suggesting 
that this agent does not behave as an intravascular "free 
flowing" tracer. However, as in the in vitro model, the area 
under myocardial time-intensity curve (AUC) was inversely 
related to coronary blood flow (F). as described by the 
equation F = K/AUC (Fig. 2). Time-related variables were 
also in agreement with tracer theory; thus myocardial washout 
rate was inversely related to coronary' blood flow (r = 0.87). 
These findings were similar to those of a study by Kaul et al. 
(33) in which the left circumflex coronary artery of dogs was 
perfused with carotid artery blood, sonicated meglumine was 
injected into the coronary cannula at variable flow rates, 
obtained by changes in perfusion pressure, and myocardial 
time-intensity curves were fitted by a gamma-variate function. 
The width of the curves obtained by Kaul et al. showed agood 
inverse correlation with transmural blood flow, even though 
adenosine was not infused. Thc same investigators confirmed 
these results in a more recent study (34) in which the mean 
myocardial transit rate of air-filled albumin microbubbles 
(Albunex, MBI) appeared to he very similar to that of radio- 
labeled red blood cells. Thus, in the pump-perfused coronary 
circulation, coronary blood flow can be quantified by myocar- 
dial contrast echocardiography according to indicator-dilution 
theory, despite the use of contrast agents (29,33) that do not 
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Figure 2. Experimental study. Inverse relation between the area under 
myocardial time-intensity cu~'e and corona O' blood flow in the pump- 
perfused experimental animal preparation. 
fulfill the characteristics of a free flowing tracer and the 
presence or absence of autoregulation. 
Rest versus hyperemic blood flow: clinical data. In contrast 
to these animal models, in the clinical setting myocardial 
contrast will mainly be applied to compare baseline with 
hyperemic perfusion. In an attempt to assess coronary blood 
flow reserve and regional myocardial blood flow distribution, 
Cheirif et al. (8), Keller et al. (9) and Agati et al. (10) injected 
ultrasound contrast medium into the left coronary artery of 
patients with single-vessel coronary artery' disease. Injections 
were performed both before and after coronary vasodilation 
with papaverine or dipyridamole. Compared with the baseline 
value, the area under the curve was increased for the normally 
pcrfused bed during coronary hyperemia, whereas it was 
decreased for the myocardium perfused by the stenotic vessel. 
These data reflect a redistribution of blood flow between the 
normal and the stenotic vascular bed, with a higher fraction of 
the contrast dose entering the normal bed during coronary 
hypcrcmia. Also, the changes in myocardial video intensity 
observed in these studies could be favored by microvascular 
recruitment in the normal bed, as opposed to vascular collapse 
downstream from the stenosis (caused by the decrease in 
pcrfusion pressure). 
Reisner et al. (35) also utilized myocardial contrast echo to 
assess coronary blood flow reserve. These investigators in- 
jected a constant dose of sonicated human albumin into the 
left main coronary artery of patients with either normal 
coronary angiograms or stenoses of the left anterior descend- 
ing coronary artery. Injections were performed both before 
and after intracoronary administration f papaverine. Relative 
to baseline, the area under the curve increased by 100% during 
coronary hyperemia inpatients with normal coronary arteries, 
increased slightly in patients with myocardium perfused by 
arteries with mild coronary lesions and decreased in patients 
with myocardium perfused by arteries with severe coronary 
stenoses. The decrease in the area under the curve observed 
after papaverine in the myocardium dependent on severely 
JACC Vol. 26, No. 1 ROVAI ET AL. 15 
July 1995:12 7 MYOCARDIAL CONTRAST ECHO EFFECT 
500 
400 
0 
~- 300 
-o 
c 200 
e5 
loo < 
0 
t { 
Baseline Dipyridamole 
Figure 3. Clinical study. Changes in the area under the myocardial 
time-intensity curve observed after dipyridamole in patients with 
normal coronary, arteries. Redrawn, with permission, from Figure 8 of 
Rovai et al. (30). 
stenotic vessels can be explained by the mechanisms just 
discussed. However, the increase in the area under the curve 
and the prolongation i myocardial transit time observed in 
patients with normal coronary arteries cannot be explained by 
a repartitioning of the dose; rather, the finding suggests a huge 
recruitment ofcoronary microcirculation (with additional con- 
trast microbubble targets) and intramyocardial blood volume 
expansion. 
Results similar to those of Reisner et al. were contempo- 
raneously obtained in our laboratories (30). To evaluate the 
effects of coronary hyperemia on myocardial contrast intensity, 
sonicated iopamidol was injected as a bolus into the normal 
left coronary artery of six patients both before and after 
intravenous dipyridamole infusion, in contrast to the in vitro 
and experimental data, coronary hyperemia resulted not in a 
reduction in the area under the curve but in values not 
significantly different from baseline (Fig. 3). Furthermore, the 
washout rate of myocardial echo contrast medium was not 
higher during hyperemia than under baseline conditions. As in 
the study of Reisner et al., these results can be attributed to an 
increased density of the coronary microcirculation during 
hyperemia. 
The only apparent exception to the previously cited studies 
is represented bythe report of Porter et al. (36). To determine 
coronary blood flow reserve in humans, sonicated albumin was 
injected into the left coronary artery of patients without 
angiographically significant coronary artery disease. A weak 
but significant inverse correlation was found between the area 
under the myocardial time-intensity curve and Doppler- 
measured coronary flow; that is, thc area under the curvc 
decreased with coronary hyperemia. However, all the patients 
studied by Porter et al. were recipients of an orthotopic heart 
transplant. Thus, even though epicardial coronary arteries 
were angiographically normal, microvascular damage, with 
inability to recruit new microvascular units, cannot be ruled 
out. Further, these investigators injected the same ultrasound 
contrast agent into the coronary, arteries of patients with 
coronary, artery disease, and they also found a significant 
increase in the area under the curve when intracoronary 
papaverine was administered after successful coronary angio- 
plasty (37). 
Given the foregoing data obtained in humans, several 
concepts eemed of importance. At the level of coronary 
microcirculation, an increase in coronary blood flow can be 
obtained by three different mechanisms alone or in combina- 
tion: 1) an increase in blood flow velocity in each perfused 
microvascular unit, 2) increased arteriolar dilation of micro- 
vascular units already perfused at baseline, and 3) recruitment 
of new microvascular units. Some of these vents can blunt the 
changes in myocardial contrast echo effect expected uring 
coronary hyperemia. Specifically, the recruitment phenome- 
non-related to the number of perfused vessels per unit 
volume--is likely to increase myocardial contrast echo inten- 
sity, thus counterbalancing the decrease in the area under the 
curve expected uring coronary hyperemia. In addition, both 
coronary dilation and recruitment expand intramyocardial 
blood volume, which prolongs the transit time of the tracer, 
thus blunting the reduction in mean transit ime expected with 
an increased rate of coronary blood flow. As a further compli- 
cation, the contrast echo agents utilized did not always comply 
with the strict requirements for a suitable tracer (15,38), as 
suggested by the consistently longer than expected myocardial 
transit ime. 
Rest versus hyperemic blood flow: experimental data. With 
these considerations in mind, a study was planned in dogs, 
using a contrast agent (Albunex, Nycomed AS, Olso, Norway) 
that was described as an intravascular free-flowing tracer for 
the study of myocardial perfusion (39). To evaluate the effects 
of coronary hyperemia on myocardial contrast echo effect, this 
agent was injected into the cannulated left circumflex artery of 
dogs under baseline conditions and during dipyridamole- 
induced coronary hyperemia. After dipyridamole, coronary 
blood flow increased by three times or more. However, once 
again, coronary hyperemia resulted not in a reduction in the 
area under the curve but in values not significantly different 
from baseline (Fig. 4), and myocardial mean contrast transit 
time showed a weak inverse correlation with coronary blood 
flow (40). These results conform with those of a recent study by 
Desir et al. (41). These investigators injected sonicated human 
albumin into the aortic root of dogs at baseline, after the 
creation of a coronary stenosis and at peak dipyridamole- 
induced hyperemia; they found a slight increase in the area 
under the myocardial time-intensity curve during coronary 
hypcremia. The ratio of the area under the curve in the normal 
and stenotic territories howed a good correlation with the 
corresponding ratio of coronary flow, as previously shown by 
Keller et al. (9). 
Conclusions and perspectives. Left ventricular myocar- 
dium can be readily opacified by the introduction ofultrasound 
contrast agents into the coronary circulation. Several studies 
have demonstrated that failure to opacify a myocardial region 
identifies a vascular bed in which no perfusion ispresent. Thus, 
it is not surprising that physicians have intuitively believed that 
16 ROVAI ET AL. JACC Vol. 26, No. 1 
MYOCARDIAL CONTRAST E( 'HO EFFE(T  July 1995:12-7 
> 
"--I 
0 
{-  
"(:3 
C 
P 
< 
300 
200 
100 
p=NS 
k 
& a. 
Baseline Dipyridamole 
Figure 4. Expcrimcntal study. Dipyridamolc-induccd changes in the 
area under the myocardial time-intensity cur,~e in the animal prepara- 
tion. 
the magnitude and time course of contrast intensity arc a 
function of coronary blood flow. Unfortunately, several vari- 
ables determine contrast intensity, which presents a challenge 
to the application of myocardial contrast echocardiography in 
the assessment of myocardial perfusion. 
The determinants of myocardial contrast echo effect in- 
clude both physical and biologic factors. The former can be 
kept constant during data collection; biologic factors are less 
easily controllable. Among biologic factors, changes in coro- 
nary blood flow and alterations in intramyocardial vascularity 
and blood volume appear to be the main determinants of 
myocardial contrast intensity. Moreover, these factors influ- 
ence contrast intensity in oppmite directions. Both the area 
under the curve and the mean myocardial contrast transit ime 
are inversely related to coronary blood flow but directly related 
to myocardial vascularity and blood volume. Accordingly, an 
increase in coronary blood flow--not accompanied by an 
increase in myocardial vascularity and volume--is accompa- 
nied by a decrease in both the area under the curve and the 
mean contrast ransit time (Fig. 5, right upper panel). Con- 
versely, an increase in coronary flow mediated by augmented 
myocardial vascularity and w)lume will produce an increase in 
both the area under the curve and the mean transit ime (Fig. 
5, right lower panel). The rate of blood flow and myocardial 
vascularity and blood volume are not independent entities and 
generally exhibit parallel changes. Thus, coronary, hypcremia is
usually accompanied by vascular ecruitment and intramyocar- 
dial blood volume expansion; and coronal 3, hypoperfusion 
could be followed by a functional occlusion of some microvas- 
cular units and a reduction in intramyocardial blood volume. 
In light of these findings, changes in myocardial contrast 
intensity cannot currently be related to alterations in coronary 
blood flow without knowledge of the underlying physiologic 
conditions. However, these considerations do not apply to the 
model of acute coronary occlusion where coronau blood flow, 
myocardial vascularity and intramyocardial b ood content all 
similarly tend to zero downstream from the occlusion. In such 
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Blood Volume 
lncreased Vascularity 
lume 
Figure 5. Schematic diagram of the effects of changes in coronary 
blood flow and volume on the myocardial time-intensity curve. An 
increase in coronary blood flow--not accompanied by an increase in 
myocardial vascularity and volume--is accompanied by a decrease in 
both the area under the curve and the mean contrast transit ime (right 
upper panel). Conversely, an increase in coronary flow mediated by 
augmented myocardial vascularity and volume produces an increase in 
both the area under the curve and the mean transit ime (right lower 
panel). 
a model myocardial contrast echocardiography can provide 
useful information regarding the extent of the area at risk (42), 
the presence of collateral channels (3-6), the presence of 
viable myocardium (6,7) and the efficacy of reperfusion (2). In 
patients with coronary stenoses myocardial perfusion should 
be assessed under maximal coronary dilation. In this condition 
a heterogeneity of myocardial perfusion occurs between re- 
gions with and without stenoses. This flow disparity should be 
studied mainly in the hyperemic images by comparing the 
different myocardial walls (9,41), instead of comparing base- 
line with hyperemic conditions. At present this information can 
be obtained only after intracoronary contrast injection. How- 
ever, it is clear that ultrasound contrast agents that can opacify 
the myocardium after a venous injection will soon become 
available (19). The new aspect of these agents also relates to 
the kinetics of their microbubbles. For years both investigators 
and pharmaceutical companies have striven to produce ultra- 
sound contrast agents imilar to intravascular t acers that can 
flow freely in the microcirculation (15,38). Conversely, these 
new agents tend to persist in the coronary circulation, behaving 
like deposit racers. It is tempting to speculate that coronary 
blood flow with these tracers hould be assessed according to 
Sapirstein's partition principle (43), i.e., by comparing contrast 
intensities of different ventricular walls, as suggested in a 
recent study by Skyba et al. (44). Finally, a significant effort is 
being made by electronic ompanies to produce new scanners 
able to record and store the echocardiographic images in a 
digital form and to give access to the unprocessed ultrasound 
data (45). A better understanding of the physical and biologic 
determinants of contrast echo intensity will be fundamental in
the clinical application of these new agents and technologies. 
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